Biologic drugmaker Amgen plans to lay off 12 percent to 15 percent of its worldwide workforce and close sites in Colorado and Washington state to fund investments, particularly launching new drugs.
Biologic drugmaker Amgen plans to lay off 12 percent to 15 percent of its worldwide workforce and close sites in Colorado and Washington state to fund investments, particularly launching new drugs.